Drug Shortage Report for SANDOZ RISEDRONATE
| Report ID | 220555 |
| Drug Identification Number | 02327295 |
| Brand name | SANDOZ RISEDRONATE |
| Common or Proper name | RISEDRONATE |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | RISEDRONATE SODIUM |
| Strength(s) | 35MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30FCT BO |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-26 |
| Estimated end date | 2024-03-08 |
| Actual end date | 2024-03-11 |
| Shortage status | Resolved |
| Updated date | 2024-03-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-03-12 | English | Compare |
| v5 | 2024-03-11 | French | Compare |
| v4 | 2024-03-11 | English | Compare |
| v3 | 2024-02-27 | English | Compare |
| v2 | 2024-02-26 | French | Compare |
| v1 | 2024-02-26 | English | Compare |
Showing 1 to 6 of 6